Research Overview

Dr. Bousvaros studies the pathogenesis and therapy of inflammatory bowel disease (IBD). Goals of Dr. Bousvaros's research include the identification of microbial pathogens that may trigger exacerbations of Crohn's disease or ulcerative colitis and the evaluation of probiotic therapies in the treatment of IBD. 

About Athos Bousvaros

Dr. Bousvaros received an MD from Duke University and an MPH from the Harvard School of Public Health. He completed fellowships at Children's Hospital Boston and Massachusetts General Hospital.

Researcher Services

Researcher Areas

  • Inflammatory Bowel Disease

Research Departments

Research Divisions

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Picoraro JA, Lee D, Heller CA, Weaver A, Hyams JS, Conklin LS, Otley A, Ziring D, Kugathasan S, Rosh JR, Mulberg A, Denson LA, Kappelman MD, Grossman AB, Bousvaros A, Park KT. Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD. Inflamm Bowel Dis. 2018 Jun 19. View abstract
  2. Chi LY, Zitomersky NL, Liu E, Tollefson S, Bender-Stern J, Naik S, Snapper S, Bousvaros A. The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 May 18; 24(6):1344-1351. View abstract
  3. Barnes J, Coleman B, Hwang S, Stolic A, Bousvaros A, Nurko S, Salinas GD. Educational needs in the diagnosis and management of pediatric functional constipation: a US survey of specialist and primary care clinicians. Postgrad Med. 2018 May; 130(4):428-435. View abstract
  4. Bousvaros A, Rufo P. Commentary: Button Batteries in Fidget Spinners: Is It Time to Push the "Panic Button"? J Pediatr Gastroenterol Nutr. 2018 Apr; 66(4):557-558. View abstract
  5. Kerur B, Machan JT, Shapiro JM, Cerezo CS, Markowitz J, Mack DR, Griffiths AM, Otley AR, Pfefferkorn MD, Rosh JR, Keljo DJ, Boyle B, Oliva-Hemker M, Kay MH, Saeed SA, Grossman AB, Sudel B, Kappelman MD, Schaefer M, Tomer G, Bousvaros A, Lerer T, Hyams JS, LeLeiko NS. Biologics Delay Progression of Crohn's Disease, but Not Early Surgery, in Children. Clin Gastroenterol Hepatol. 2018 Mar 02. View abstract
  6. Levine A, Kori M, Kierkus J, Sigall Boneh R, Sladek M, Escher JC, Wine E, Yerushalmi B, Amil Dias J, Shaoul R, Veereman Wauters G, Boaz M, Abitbol G, Bousvaros A, Turner D. Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial. Gut. 2018 Feb 02. View abstract
  7. Zimmerman LA, Zalieckas JM, Shamberger RC, Bousvaros A. Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab. J Pediatr Surg. 2018 Jul; 53(7):1330-1333. View abstract
  8. Flett KB, Bousvaros A, Carpenter J, Millrinen CE, Martin P, Sandora TJ. Reducing Redundant Anaerobic Therapy Through Spaced Education and Antimicrobial Stewardship Interventions. J Pediatric Infect Dis Soc. 2017 Nov 20. View abstract
  9. Shouval DS, Konnikova L, Griffith AE, Wall SM, Biswas A, Werner L, Nunberg M, Kammermeier J, Goettel JA, Anand R, Chen H, Weiss B, Li J, Loizides A, Yerushalmi B, Yanagi T, Beier R, Conklin LS, Ebens CL, Santos FGMS, Sherlock M, Goldsmith JD, Kotlarz D, Glover SC, Shah N, Bousvaros A, Uhlig HH, Muise AM, Klein C, Snapper SB. Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD. Inflamm Bowel Dis. 2017 11; 23(11):1950-1961. View abstract
  10. Badran YR, Dedeoglu F, Leyva Castillo JM, Bainter W, Ohsumi TK, Bousvaros A, Goldsmith JD, Geha RS, Chou J. Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration. J Exp Med. 2017 Jul 03; 214(7):1937-1947. View abstract
  11. Kerur B, Litman HJ, Stern JB, Weber S, Lightdale JR, Rufo PA, Bousvaros A. Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis. World J Gastroenterol. 2017 May 14; 23(18):3322-3329. View abstract
  12. Sheu J, Chun S, O'Day E, Cheung S, Cruz R, Lightdale JR, Fishman DS, Bousvaros A, Huang JS. Outcomes From Pediatric Gastroenterology Maintenance of Certification Using Web-based Modules. J Pediatr Gastroenterol Nutr. 2017 May; 64(5):671-678. View abstract
  13. Bousvaros A. From "Jarts" to "Zen Magnets": Protecting Our Children from Dangerous Toys. J Pediatr. 2017 Jul; 186:6-7. View abstract
  14. Goettel J, Kotlarz D, Illig D, Canavan J, Allegretti J, Hamilton M, Kelly R, Griffith A, Carellas M, Nelina A, Bousvaros A, Korzenik J, Snapper S. O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis. Inflamm Bowel Dis. 2017 Feb; 23 Suppl 1:S4. View abstract
  15. Keerthy D, Youk A, Srinath AI, Malas N, Bujoreanu S, Bousvaros A, Keljo D, DeMaso DR, Szigethy EM. Effect of Psychotherapy on Health Care Utilization in Children With Inflammatory Bowel Disease and Depression. J Pediatr Gastroenterol Nutr. 2016 12; 63(6):658-664. View abstract
  16. Shouval DS, Biswas A, Kang YH, Griffith AE, Konnikova L, Mascanfroni ID, Redhu NS, Frei SM, Field M, Doty AL, Goldsmith JD, Bhan AK, Loizides A, Weiss B, Yerushalmi B, Yanagi T, Lui X, Quintana FJ, Muise AM, Klein C, Horwitz BH, Glover SC, Bousvaros A, Snapper SB. Interleukin 1ß Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. Gastroenterology. 2016 12; 151(6):1100-1104. View abstract
  17. Zimmerman LA, Saites CG, Bairdain S, Lien C, Zurakowski D, Shamberger RC, Linden BC, Bousvaros A. Postoperative Complications in Children With Crohn Disease Treated With Infliximab. J Pediatr Gastroenterol Nutr. 2016 09; 63(3):352-6. View abstract
  18. Liew WK, Pacak CA, Visyak N, Darras BT, Bousvaros A, Kang PB. Longitudinal Patterns of Thalidomide Neuropathy in Children and Adolescents. J Pediatr. 2016 Nov; 178:227-232. View abstract
  19. Ardura MI, Toussi SS, Siegel JD, Lu Y, Bousvaros A, Crandall W. NASPGHAN Clinical Report: Surveillance, Diagnosis, and Prevention of Infectious Diseases in Pediatric Patients With Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-a Inhibitors. J Pediatr Gastroenterol Nutr. 2016 07; 63(1):130-55. View abstract
  20. Levine A, Keljo D, DeMaso D, Bousvaros A, Szigethy E. O-017 YI Inflammatory Versus Non-inflammatory Predictors of Specific Depressive Symptoms in a Large Pediatric Cohort with IBD. Inflamm Bowel Dis. 2016 Mar; 22 Suppl 1:S6. View abstract
  21. Doshi-Velez F, Avillach P, Palmer N, Bousvaros A, Ge Y, Fox K, Steinberg G, Spettell C, Juster I, Kohane I. Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders. Inflamm Bowel Dis. 2015 Oct; 21(10):2281-8. View abstract
  22. Bousvaros A. Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug. Inflamm Bowel Dis. 2015 Aug; 21(8):1750-1. View abstract
  23. Szigethy E, Youk AO, Gonzalez-Heydrich J, Bujoreanu SI, Weisz J, Fairclough D, Ducharme P, Jones N, Lotrich F, Keljo D, Srinath A, Bousvaros A, Kupfer D, DeMaso DR. Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease. Inflamm Bowel Dis. 2015 Jun; 21(6):1321-8. View abstract
  24. Oliva-Hemker M, Hutfless S, Al Kazzi ES, Lerer T, Mack D, LeLeiko N, Griffiths A, Cabrera J, Otley A, Rick J, Bousvaros A, Rosh J, Grossman A, Saeed S, Kay M, Carvalho R, Keljo D, Pfefferkorn M, Faubion W, Kappelman M, Sudel B, Schaefer ME, Markowitz J, Hyams JS. Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort. J Pediatr. 2015 Sep; 167(3):527-32.e1-3. View abstract
  25. Grossi V, Lerer T, Griffiths A, LeLeiko N, Cabrera J, Otley A, Rick J, Mack D, Bousvaros A, Rosh J, Grossman A, Saeed S, Kay M, Boyle B, Oliva-Hemker M, Keljo D, Pfefferkorn M, Faubion W, Kappelman MD, Sudel B, Markowitz J, Hyams JS. Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease. Clin Gastroenterol Hepatol. 2015 Oct; 13(10):1748-56. View abstract
  26. Waters AM, Teitelbaum DH, Thorne V, Bousvaros A, Noel RA, Beierle EA. Surgical management and morbidity of pediatric magnet ingestions. J Surg Res. 2015 Nov; 199(1):137-40. View abstract
  27. Zitomersky NL, Atkinson BJ, Fournier K, Mitchell PD, Stern JB, Butler MC, Ashworth L, Hauenstein S, Heiner L, Chuang E, Singh S, Bousvaros A. Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD. Inflamm Bowel Dis. 2015 Feb; 21(2):307-14. View abstract
  28. Baffour-Awuah NY, Fleet S, Montgomery RK, Baker SS, Butler JL, Campbell C, Tischfield S, Mitchell PD, Allende-Richter S, Moon JE, Fishman L, Bousvaros A, Fox V, Kuokkanen M, Grand RJ, Hirschhorn JN. Functional significance of single nucleotide polymorphisms in the lactase gene in diverse US patients and evidence for a novel lactase persistence allele at -13909 in those of European ancestry. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2):182-91. View abstract
  29. Shillingford NM, Calicchio ML, Teot LA, Boyd T, Kurek KC, Goldsmith JD, Bousvaros A, Perez-Atayde AR, Kozakewich HP. Villin immunohistochemistry is a reliable method for diagnosing microvillus inclusion disease. Am J Surg Pathol. 2015 Feb; 39(2):245-50. View abstract
  30. Turner D, Doveh E, Cohen A, Wilson ML, Grossman AB, Rosh JR, Lu Y, Bousvaros A, Deslandres C, Noble A, Baldassano RN, Levine A, Lerner A, Wilson DC, Griffiths AM. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study. Gut. 2015 Dec; 64(12):1898-904. View abstract
  31. Srinath AI, Goyal A, Zimmerman LA, Newara MC, Kirshner MA, McCarthy FN, Keljo D, Binion D, Bousvaros A, DeMaso DR, Youk A, Szigethy EM. Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. Inflamm Bowel Dis. 2014 Aug; 20(8):1329-40. View abstract
  32. Bousvaros A. Benefit/risk assessment of biologic monotherapy vs combination therapy in Crohn's Remains Challenging. Gastroenterology. 2014 Aug; 147(2):540. View abstract
  33. Zimmerman LA, Shamberger RC, Valim C, Bousvaros A. The effect of immunomodulators and biologics on indication for surgical bowel resection in children with Crohn's disease. Inflamm Bowel Dis. 2014 Jun; 20(6):1015-20. View abstract
  34. Regan BP, Bousvaros A. Pediatric ulcerative colitis: a practical guide to management. Paediatr Drugs. 2014 Jun; 16(3):189-98. View abstract
  35. Lu Y, Bousvaros A. Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapy. Gastroenterol Hepatol (N Y). 2014 Jun; 10(6):355-63. View abstract
  36. Szigethy E, Bujoreanu SI, Youk AO, Weisz J, Benhayon D, Fairclough D, Ducharme P, Gonzalez-Heydrich J, Keljo D, Srinath A, Bousvaros A, Kirshner M, Newara M, Kupfer D, DeMaso DR. Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry. 2014 Jul; 53(7):726-35. View abstract
  37. Clark JG, Srinath AI, Youk AO, Kirshner MA, McCarthy FN, Keljo DJ, Bousvaros A, DeMaso DR, Szigethy EM. Predictors of depression in youth with Crohn disease. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):569-73. View abstract
  38. Benhayon D, Youk A, McCarthy FN, Davis S, Keljo DJ, Bousvaros A, Fairclough D, Kupfer D, Buysse DJ, Szigethy EM. Authors' response. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):e51. View abstract
  39. Szigethy EM, Youk AO, Benhayon D, Fairclough DL, Newara MC, Kirshner MA, Bujoreanu SI, Mrakotsky C, Bousvaros A, Srinath AI, Keljo DJ, Kupfer DJ, DeMaso DR. Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):574-81. View abstract
  40. Rubinstein E, Stolz LE, Sheffer AL, Stevens C, Bousvaros A. Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. BMC Gastroenterol. 2014 Apr 09; 14:71. View abstract
  41. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb; 58(3):309-18. View abstract
  42. Bousvaros A, Bonta C, Gilger M, Noel RA. Advocating for child health: how the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition took action against high-powered magnets. J Pediatr. 2014 Jan; 164(1):4-5.e1. View abstract
  43. Crandall WV, Baldassano R, Bousvaros A, Denson LA, Gupta N, Mackner LM. NASPGHAN single-topic symposium: discovering the future of pediatric IBD care. J Pediatr Gastroenterol Nutr. 2014 Jan; 58(1):130-8. View abstract
  44. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb; 58(3):e44-100. View abstract
  45. Zitomersky NL, Levine AE, Atkinson BJ, Harney KM, Verhave M, Bousvaros A, Lightdale JR, Trenor CC. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):343-7. View abstract
  46. Lamousé-Smith ES, Weber S, Rossi RF, Neinstedt LJ, Mosammaparast N, Sandora TJ, McAdam AJ, Bousvaros A. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):293-7. View abstract
  47. Benhayon D, Youk A, McCarthy FN, Davis S, Keljo DJ, Bousvaros A, Fairclough D, Kupfer D, Buysse DJ, Szigethy EM. Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):335-42. View abstract
  48. Gray FL, Turner CG, Zurakowski D, Bousvaros A, Linden BC, Shamberger RC, Lillehei CW. Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis. J Pediatr Surg. 2013 Jul; 48(7):1540-5. View abstract
  49. Zitomersky NL, Atkinson BJ, Franklin SW, Mitchell PD, Snapper SB, Comstock LE, Bousvaros A. Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS One. 2013; 8(6):e63686. View abstract
  50. Jacobson DL, Bousvaros A, Ashworth L, Carey R, Shrier LA, Burchett SK, Renna H, Lu Y. Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Jun; 19(7):1441-9. View abstract
  51. Zimmerman LA, Srinath AI, Goyal A, Bousvaros A, Ducharme P, Szigethy E, Nurko S. The overlap of functional abdominal pain in pediatric Crohn's disease. Inflamm Bowel Dis. 2013 Mar-Apr; 19(4):826-31. View abstract
  52. Bern EM, Bousvaros A. Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum. Expert Rev Clin Immunol. 2013 Feb; 9(2):117-27. View abstract
  53. Zeisler B, Lerer T, Markowitz J, Mack D, Griffiths A, Bousvaros A, Keljo D, Rosh J, Evans J, Kappelman M, Otley A, Kay M, Grossman A, Saeed S, Carvalho R, Oliva-Hemker M, Faubion W, Sudel B, Pfefferkorn M, Ashai-Khan F, Leleiko N, Hyams J. Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013 Jan; 56(1):12-8. View abstract
  54. Mrakotsky C, Forbes PW, Bernstein JH, Grand RJ, Bousvaros A, Szigethy E, Waber DP. Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease. J Int Neuropsychol Soc. 2013 Jan; 19(1):96-109. View abstract
  55. Thompson RD, Craig A, Crawford EA, Fairclough D, Gonzalez-Heydrich J, Bousvaros A, Noll RB, DeMaso DR, Szigethy E. Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms. J Clin Psychol Med Settings. 2012 Sep; 19(3):329-37. View abstract
  56. Hussain SZ, Bousvaros A, Gilger M, Mamula P, Gupta S, Kramer R, Noel RA. Management of ingested magnets in children. J Pediatr Gastroenterol Nutr. 2012 Sep; 55(3):239-42. View abstract
  57. Freiman M, Perez-Rossello JM, Callahan MJ, Bittman M, Mulkern RV, Bousvaros A, Warfield SK. Characterization of fast and slow diffusion from diffusion-weighted MRI of pediatric Crohn's disease. J Magn Reson Imaging. 2013 Jan; 37(1):156-63. View abstract
  58. Otley A, LeLeiko N, Langton C, Lerer T, Mack D, Evans J, Pfefferkorn M, Carvalho R, Rosh J, Griffiths A, Oliva-Hemker M, Kay M, Bousvaros A, Stephens M, Samson C, Grossman A, Keljo D, Markowitz J, Hyams J. Budesonide use in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2012 Aug; 55(2):200-4. View abstract
  59. Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol. 2012 Sep; 107(9):1399-406. View abstract
  60. Papa E, Docktor M, Smillie C, Weber S, Preheim SP, Gevers D, Giannoukos G, Ciulla D, Tabbaa D, Ingram J, Schauer DB, Ward DV, Korzenik JR, Xavier RJ, Bousvaros A, Alm EJ. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One. 2012; 7(6):e39242. View abstract
  61. Natter MD, Quan J, Ortiz DM, Bousvaros A, Ilowite NT, Inman CJ, Marsolo K, McMurry AJ, Sandborg CI, Schanberg LE, Wallace CA, Warren RW, Weber GM, Mandl KD. An i2b2-based, generalizable, open source, self-scaling chronic disease registry. J Am Med Inform Assoc. 2013 Jan 01; 20(1):172-9. View abstract
  62. Thompson RD, Craig AE, Mrakotsky C, Bousvaros A, DeMaso DR, Szigethy E. Using the Children's Depression Inventory in youth with inflammatory bowel disease: support for a physical illness-related factor. Compr Psychiatry. 2012 Nov; 53(8):1194-9. View abstract
  63. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012 Apr 16; 13(9):R79. View abstract
  64. Docktor MJ, Paster BJ, Abramowicz S, Ingram J, Wang YE, Correll M, Jiang H, Cotton SL, Kokaras AS, Bousvaros A. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2012 May; 18(5):935-42. View abstract
  65. Ashworth LA, Billett A, Mitchell P, Nuti F, Siegel C, Bousvaros A. Lymphoma risk in children and young adults with inflammatory bowel disease: analysis of a large single-center cohort. Inflamm Bowel Dis. 2012 May; 18(5):838-43. View abstract
  66. Bousvaros A. "Tac"kling a difficult problem: using tacrolimus to maintain remission in ulcerative colitis. J Clin Gastroenterol. 2011 Jul; 45(6):479-80. View abstract
  67. Lee JJ, Colman RJ, Mitchell PD, Atmadja ML, Bousvaros A, Lightdale JR. Agreement between patient- and physician-completed Pediatric Ulcerative Colitis Activity Index scores. J Pediatr Gastroenterol Nutr. 2011 Jun; 52(6):708-13. View abstract
  68. Hyams JS, Lerer T, Mack D, Bousvaros A, Griffiths A, Rosh J, Otley A, Evans J, Stephens M, Kay M, Keljo D, Pfefferkorn M, Saeed S, Crandall W, Michail S, Kappelman MD, Grossman A, Samson C, Sudel B, Oliva-Hemker M, Leleiko N, Markowitz J. Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study. Am J Gastroenterol. 2011 May; 106(5):981-7. View abstract
  69. Turner D, Travis SP, Griffiths AM, Ruemmele FM, Levine A, Benchimol EI, Dubinsky M, Alex G, Baldassano RN, Langer JC, Shamberger R, Hyams JS, Cucchiara S, Bousvaros A, Escher JC, Markowitz J, Wilson DC, van Assche G, Russell RK. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol. 2011 Apr; 106(4):574-88. View abstract
  70. Rakoff-Nahoum S, Bousvaros A. Innate and adaptive immune connections in inflammatory bowel diseases. Curr Opin Gastroenterol. 2010 Nov; 26(6):572-7. View abstract
  71. Watson S, Pensabene L, Mitchell P, Bousvaros A. Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis. Inflamm Bowel Dis. 2011 Jan; 17(1):22-9. View abstract
  72. Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo D, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Langton CR, Crandall W. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr. 2010 Aug; 51(2):140-5. View abstract
  73. Bousvaros A. Use of immunomodulators and biologic therapies in children with inflammatory bowel disease. Expert Rev Clin Immunol. 2010 Jul; 6(4):659-66. View abstract
  74. Schaefer ME, Machan JT, Kawatu D, Langton CR, Markowitz J, Crandall W, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo DJ, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Kappelman MD, Saeed SA, Hyams JS, Leleiko NS. Factors that determine risk for surgery in pediatric patients with Crohn's disease. Clin Gastroenterol Hepatol. 2010 Sep; 8(9):789-94. View abstract
  75. Lu Y, Bousvaros A. Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy. J Pediatr Gastroenterol Nutr. 2010 May; 50(5):562-5. View abstract
  76. Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Stephens M, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Grossman A, Tomer G, Kay M, Crandall W, Oliva-Hemker M, Keljo D, LeLeiko N, Markowitz J. Outcome following infliximab therapy in children with ulcerative colitis. Am J Gastroenterol. 2010 Jun; 105(6):1430-6. View abstract
  77. Qualia C, Bousvaros A. Probiotic for new onset ulcerative colitis in children: baby's got bac(teria). Inflamm Bowel Dis. 2010 Jan; 16(1):177-8. View abstract
  78. Bousvaros A, Turner D, Vitito L. . Monitoring Disease Activity in Pediatric IBD Patients (monograph). Children's Digestive Health and Nutrition Foundation 2009 . 2010. View abstract
  79. Lu Y, Bousvaros A. Healthcare burden of inflammatory bowel disease in the United States: more than pain and diarrhea. Inflamm Bowel Dis. 2009 Nov; 15(11):1767-8. View abstract
  80. Lu Y, Jacobson D, Bousvaros A. Immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009 Sep; 15(9):1417-23. View abstract
  81. Colletti RB, Baldassano RN, Milov DE, Margolis PA, Bousvaros A, Crandall WV, Crissinger KD, D'Amico MA, Day AS, Denson LA, Dubinsky M, Ebach DR, Hoffenberg EJ, Kader HA, Keljo DJ, Leibowitz IH, Mamula P, Pfefferkorn MD, Qureshi MA. Variation in care in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2009 Sep; 49(3):297-303. View abstract
  82. Lillehei CW, Leichtner A, Bousvaros A, Shamberger RC. Restorative proctocolectomy and ileal pouch-anal anastomosis in children. Dis Colon Rectum. 2009 Sep; 52(9):1645-9. View abstract
  83. Turner D, Hyams J, Markowitz J, Lerer T, Mack DR, Evans J, Pfefferkorn M, Rosh J, Kay M, Crandall W, Keljo D, Otley AR, Kugathasan S, Carvalho R, Oliva-Hemker M, Langton C, Mamula P, Bousvaros A, LeLeiko N, Griffiths AM. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis. 2009 Aug; 15(8):1218-23. View abstract
  84. Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Kugathasan S, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Mamula P, Kay M, Crandall W, Oliva-Hemker M, Keljo D, LeLeiko N, Markowitz J. Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis. 2009 Jun; 15(6):816-22. View abstract
  85. Keljo DJ, Markowitz J, Langton C, Lerer T, Bousvaros A, Carvalho R, Crandall W, Evans J, Griffiths A, Kay M, Kugathasan S, LeLeiko N, Mack D, Mamula P, Moyer MS, Oliva-Hemker M, Otley A, Pfefferkorn M, Rosh J, Hyams JS. Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflamm Bowel Dis. 2009 Mar; 15(3):383-7. View abstract
  86. Pfefferkorn M, Burke G, Griffiths A, Markowitz J, Rosh J, Mack D, Otley A, Kugathasan S, Evans J, Bousvaros A, Moyer MS, Wyllie R, Oliva-Hemker M, Carvalho R, Crandall W, Keljo D, Walters TD, LeLeiko N, Hyams J. Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr. 2009 Feb; 48(2):168-74. View abstract
  87. Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, McNeal MM, Gregas MC, Burchett SK, Bousvaros A. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009 Feb; 104(2):444-53. View abstract
  88. Bousvaros A, Goldsmith J, Strople J, Vitito L. . Making the right diagnosis: differentiating between Crohn disease and ulcerative colitis in children and young adults. . 2009. View abstract
  89. Bousvaros A. . Approach to clinical diagnosis of inflammatory bowel disease. In: Walker-Smith JA, Lebenthal E, Branski D. Pediatric Inflammatory Bowel Disease: Perspective and consequences. 2009; 123-137. View abstract
  90. Kappelman MD, Bousvaros A. Nutritional concerns in pediatric inflammatory bowel disease patients. Mol Nutr Food Res. 2008 Aug; 52(8):867-74. View abstract
  91. Punati J, Markowitz J, Lerer T, Hyams J, Kugathasan S, Griffiths A, Otley A, Rosh J, Pfefferkorn M, Mack D, Evans J, Bousvaros A, Moyer MS, Wyllie R, Oliva-Hemker M, Mezoff A, Leleiko N, Keljo D, Crandall W. Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis. 2008 Jul; 14(7):949-54. View abstract
  92. Abell TL, Adams KA, Boles RG, Bousvaros A, Chong SK, Fleisher DR, Hasler WL, Hyman PE, Issenman RM, Li BU, Linder SL, Mayer EA, McCallum RW, Olden K, Parkman HP, Rudolph CD, Taché Y, Tarbell S, Vakil N. Cyclic vomiting syndrome in adults. Neurogastroenterol Motil. 2008 Apr; 20(4):269-84. View abstract
  93. Bousvaros A, Morley-Fletcher A, Pensabene L, Cucchiara S. Research and clinical challenges in paediatric inflammatory bowel disease. Dig Liver Dis. 2008 Jan; 40(1):32-8. View abstract
  94. Szigethy E, Kenney E, Carpenter J, Hardy DM, Fairclough D, Bousvaros A, Keljo D, Weisz J, Beardslee WR, Noll R, DeMaso DR. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry. 2007 Oct; 46(10):1290-8. View abstract
  95. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007 Dec; 5(12):1424-9. View abstract
  96. Kugathasan S, Nebel J, Skelton JA, Markowitz J, Keljo D, Rosh J, LeLeiko N, Mack D, Griffiths A, Bousvaros A, Evans J, Mezoff A, Moyer S, Oliva-Hemker M, Otley A, Pfefferkorn M, Crandall W, Wyllie R, Hyams J. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr. 2007 Nov; 151(5):523-7. View abstract
  97. Kappelman MD, Bousvaros A, Hyams J, Markowitz J, Pfefferkorn M, Kugathasan S, Rosh J, Otley A, Mack D, Griffiths A, Evans J, Grand R, Langton C, Kleinman K, Finkelstein JA. Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis. 2007 Jul; 13(7):890-5. View abstract
  98. Rufo PA, Bousvaros A. Challenges and progress in pediatric inflammatory bowel disease. Curr Opin Gastroenterol. 2007 Jul; 23(4):406-12. View abstract
  99. Mack DR, Langton C, Markowitz J, LeLeiko N, Griffiths A, Bousvaros A, Evans J, Kugathasan S, Otley A, Pfefferkorn M, Rosh J, Mezoff A, Moyer S, Oliva-Hemker M, Rothbaum R, Wyllie R, delRosario JF, Keljo D, Lerer T, Hyams J. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics. 2007 Jun; 119(6):1113-9. View abstract
  100. Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007 May; 44(5):653-74. View abstract
  101. Hilarie Staton, Joe Staton, Athos Bousvaros, Janis Arnold, Joel Rosh, Tony Otley, Eva Szigethy. Pete Learns About Crohn's and Colitis. 2007. View abstract
  102. Hait EJ, Bousvaros A, Schuman M, Shamberger RC, Lillehei CW. Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery. J Pediatr Surg. 2007 Jan; 42(1):31-4; discussion 34-5. View abstract
  103. Semrin G, Fishman DS, Bousvaros A, Zholudev A, Saunders AC, Correia CE, Nemeth E, Grand RJ, Weinstein DA. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis. 2006 Dec; 12(12):1101-6. View abstract
  104. Bousvaros A, Sylvester F, Kugathasan S, Szigethy E, Fiocchi C, Colletti R, Otley A, Amre D, Ferry G, Czinn SJ, Splawski JB, Oliva-Hemker M, Hyams JS, Faubion WA, Kirschner BS, Dubinsky MC. Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006 Sep; 12(9):885-913. View abstract
  105. Jaff JC, Arnold J, Bousvaros A. Effective advocacy for patients with inflammatory bowel disease: communication with insurance companies, school administrators, employers, and other health care overseers. Inflamm Bowel Dis. 2006 Aug; 12(8):814-23. View abstract
  106. Otley AR, Griffiths AM, Hale S, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Markowitz J, Mack D, Oliva-Hemker M, Wyllie R, Rothbaum R, Bousvaros A, Del Rosario JF, Evans J, Blanchard W, Hyams J. Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006 Aug; 12(8):684-91. View abstract
  107. Faubion WA, Bousvaros A. Medical therapy for refractory pediatric Crohn's disease. Clin Gastroenterol Hepatol. 2006 Oct; 4(10):1199-213. View abstract
  108. Markowitz J, Hyams J, Mack D, Leleiko N, Evans J, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Otley A, Griffiths A, Moyer MS, Oliva-Hemker M, Wyllie R, Rothbaum R, Bousvaros A, Del Rosario JF, Hale S, Lerer T. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol. 2006 Sep; 4(9):1124-9. View abstract
  109. Hyams J, Markowitz J, Lerer T, Griffiths A, Mack D, Bousvaros A, Otley A, Evans J, Pfefferkorn M, Rosh J, Rothbaum R, Kugathasan S, Mezoff A, Wyllie R, Tolia V, delRosario JF, Moyer MS, Oliva-Hemker M, Leleiko N. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol. 2006 Sep; 4(9):1118-23. View abstract
  110. Hande S, Wilson-Rich N, Bousvaros A, Zholudev A, Maurer R, Banks P, Makrauer F, Reddy S, Burakoff R, Friedman S. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Inflamm Bowel Dis. 2006 Apr; 12(4):251-7. View abstract
  111. L Fishman and A Bousvaros. Gastrointestinal issues in developmentally disabled children. LI Rubin and AC Crocker eds. Medical Care for children and adults with developmental disabilities. 2006; 307-324. View abstract
  112. Rufo PA, Bousvaros A. Current therapy of inflammatory bowel disease in children. Paediatr Drugs. 2006; 8(5):279-302. View abstract
  113. Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, Kugathasan S, Pfefferkorn M, Tolia V, Evans J, Treem W, Wyllie R, Rothbaum R, del Rosario J, Katz A, Mezoff A, Oliva-Hemker M, Lerer T, Griffiths A. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr. 2005 Oct; 41(4):416-21. View abstract
  114. Bousvaros A, Guandalini S, Baldassano RN, Botelho C, Evans J, Ferry GD, Goldin B, Hartigan L, Kugathasan S, Levy J, Murray KF, Oliva-Hemker M, Rosh JR, Tolia V, Zholudev A, Vanderhoof JA, Hibberd PL. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis. 2005 Sep; 11(9):833-9. View abstract
  115. Markowitz J, Markowitz JE, Bousvaros A, Crandall W, Faubion W, Kirschner BS, Perrault J, Rosh J, Winter H. Workshop report: prevention of postoperative recurrence in Crohn's disease. J Pediatr Gastroenterol Nutr. 2005 Aug; 41(2):145-51. View abstract
  116. Zholudev A, Rifai N, Zurakowski D, Bousvaros A. Normal homocysteine levels in a population of children with inflammatory bowel disease. Inflamm Bowel Dis. 2005 Jun; 11(6):620-1. View abstract
  117. Hait E, Hait L, Bousvaros A, Grand R. Pediatric inflammatory bowel disease: what children can teach adults. Inflamm Bowel Dis. 2005 Jun; 11(6):519-27. View abstract
  118. Griffiths AM, Otley AR, Hyams J, Quiros AR, Grand RJ, Bousvaros A, Feagan BG, Ferry GR. A review of activity indices and end points for clinical trials in children with Crohn's disease. Inflamm Bowel Dis. 2005 Feb; 11(2):185-96. View abstract
  119. Kappelman M, Bousvaros A. Probiotic Therapies: the crossroads of traditional and alternative medicine. Practical Gastroenterology. 2005; 4:20-36. View abstract
  120. Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004 Nov; 99(11):2235-41. View abstract
  121. Szigethy E, Levy-Warren A, Whitton S, Bousvaros A, Gauvreau K, Leichtner AM, Beardslee WR. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr. 2004 Oct; 39(4):395-403. View abstract
  122. Bousvaros A. Mucosal healing in children with Crohn's disease: appropriate therapeutic goal or medical overkill? Inflamm Bowel Dis. 2004 Jul; 10(4):481-3. View abstract
  123. Glickman JN, Bousvaros A, Farraye FA, Zholudev A, Friedman S, Wang HH, Leichtner AM, Odze RD. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol. 2004 Feb; 28(2):190-7. View abstract
  124. Rhee SJ and Bousvaros A. Immunosuppressive therapies. Walker WA, Goulet O, Kleinman R, Sherman P, Shneider B, Sanderson I eds. Pediatric Gastrointestinal Disease. 2004; 2:2015-2044. View abstract
  125. Escher J, Bousvaros A. Pediatric Crohn's disease. Johnson L ed. Encyclopedia of Gastroenterology. 2004; 520-527. View abstract
  126. Higuchi L and Bousvaros A. Ulcerative colitis. Guandalini ed, Textbook of Pediatric Gastroenterology. 2004; 385-418. View abstract
  127. Russell GJ, Bousvaros A, Walker WA. Gastroenterologic and Liver Disorders. Stiehm ER, Ochs H, Winkelstein J eds. Immunologic disorders in infants and children. 2004; 1055-1102. View abstract
  128. Bousvaros A. Gastroenterology questions for the American Academy of Pediatrics PREP course. Available on www.pedialink.org. 2004. View abstract
  129. Sands BE, Arsenault JE, Rosen MJ, Alsahli M, Bailen L, Banks P, Bensen S, Bousvaros A, Cave D, Cooley JS, Cooper HL, Edwards ST, Farrell RJ, Griffin MJ, Hay DW, John A, Lidofsky S, Olans LB, Peppercorn MA, Rothstein RI, Roy MA, Saletta MJ, Shah SA, Warner AS, Wolf JL, Vecchio J, Winter HS, Zawacki JK. Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol. 2003 Dec; 98(12):2712-8. View abstract
  130. Rhee SJ, Bousvaros A. Blocking lymphocyte adhesion: new treatment for sticky cases of Crohn disease? J Pediatr Gastroenterol Nutr. 2003 Aug; 37(2):211-3. View abstract
  131. Heuschkel RB, Fletcher K, Hill A, Buonomo C, Bousvaros A, Nurko S. Isolated neonatal swallowing dysfunction: a case series and review of the literature. Dig Dis Sci. 2003 Jan; 48(1):30-5. View abstract
  132. Bousvaros A, Dubinsky M, Isaacs K, Atkinson H. Webcast: Crohn's and colitis Foundation - Management of IBD in special populations. Available on www.ccfa.org. 2003. View abstract
  133. Bousvaros A. Nutritional therapy of inflammatory bowel disease. Caballero B, Trugo L, Finglas P eds. Encyclopedia of Food Sciences and Nutrition. 2003; 3315-3320. View abstract
  134. Bousvaros A and Puder M. Feeding tubes. Puder M, Hansen A eds. Manual of Neonatal Surgical Care. 2003; 303-314. View abstract
  135. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci. 2002 Nov; 47(11):2625-34. View abstract
  136. Rosen R, Integlia MJ, Bousvaros A. Severe pancytopenia from thiopurine methyltransferase deficiency: a preventable complication of 6-mercaptopurine therapy in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2002 Nov; 35(5):695-9. View abstract
  137. Bousvaros A. Blame Canada: growing questions about budesonide. Inflamm Bowel Dis. 2002 May; 8(3):235. View abstract
  138. Heuschkel R, Afzal N, Wuerth A, Zurakowski D, Leichtner A, Kemper K, Tolia V, Bousvaros A. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol. 2002 Feb; 97(2):382-8. View abstract
  139. Verhave M, Baldassano RN, Bousvaros A, Grand RJ, Kirschner BS. Research agenda for pediatric gastroenterology, hepatology and nutrition: chronic inflammatory bowel disease. Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation. J Pediatr Gastroenterol Nutr. 2002; 35 Suppl 3:S286-90. View abstract
  140. Bousvaros A. Board review questions in pediatric gastroenterology for the American Academy of Pediatrics PREP the course. 16 Questions per year for 6 years (2002-2008). 2002. View abstract
  141. Jones M, Campbell KA, Duggan C, Young G, Bousvaros A, Higgins L, Mullen E. Multiple micronutrient deficiencies in a child fed an elemental formula. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):602-5. View abstract
  142. Higuchi LM, Joffe S, Neufeld EJ, Weisdorf S, Rosh J, Murch S, Devenyi A, Thompson JF, Lewis JD, Bousvaros A. Inflammatory bowel disease associated with immune thrombocytopenic purpura in children. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):582-7. View abstract
  143. Srivastava M, Zurakowski D, Cheifetz P, Leichtner A, Bousvaros A. Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):548-53. View abstract
  144. Heuschkel R, Kim S, Korf B, Schneider G, Bousvaros A. Abdominal migraine in children with neurofibromatosis type 1: a case series and review of gastrointestinal involvement in NF1. J Pediatr Gastroenterol Nutr. 2001 Aug; 33(2):149-54. View abstract
  145. Bousvaros A, Mueller B. Thalidomide in gastrointestinal disorders. Drugs. 2001; 61(6):777-87. View abstract
  146. Bitton A, Peppercorn MA, Antonioli DA, Niles JL, Shah S, Bousvaros A, Ransil B, Wild G, Cohen A, Edwardes MD, Stevens AC. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001 Jan; 120(1):13-20. View abstract
  147. Higuchi L, Bousvaros A. Epidemiology and diagnosis of inflammatory bowel disease. Bonis ed., Up to Date. 2001; 9. View abstract
  148. Furuta GT, Nurko S, Bousvaros A, Antonioli D, Badizadegan K. The spectrum of pediatric gastroesophageal reflux. JAMA. 2000 Dec 27; 284(24):3125-6. View abstract
  149. Bousvaros A, Kirschner BS, Werlin SL, Parker-Hartigan L, Daum F, Freeman KB, Balint JP, Day AS, Griffiths AM, Zurakowski D, Ferry GD, Leichtner AM. Oral tacrolimus treatment of severe colitis in children. J Pediatr. 2000 Dec; 137(6):794-9. View abstract
  150. Bousvaros A, Marcon M, Treem W, Waters P, Issenman R, Couper R, Burnell R, Rosenberg A, Rabinovich E, Kirschner BS. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Dig Dis Sci. 1999 Dec; 44(12):2500-7. View abstract
  151. Walsh SV, Antonioli DA, Goldman H, Fox VL, Bousvaros A, Leichtner AM, Furuta GT. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol. 1999 Apr; 23(4):390-6. View abstract
  152. Bousvaros A, Leichtner A, Zurakowski D, Kwon J, Law T, Keough K, Fishman S. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig Dis Sci. 1999 Feb; 44(2):424-30. View abstract
  153. Bousvaros A, Murray K, Leichtner A. Crohn's disease in children and adolescents. Bonis ed, Up to Date (CD-ROM). 1999; 8. View abstract
  154. Bousvaros A. Gastrointestinal Manifestations of Primary Immunodeficiencies. Wyllie R, Hyams JS. Pediatric Gastrointestinal Disease. 1999; 381-389. View abstract
  155. Bousvaros A, Murray K, Leichtner A. Ulcerative Colitis in children and adolescents. Bonis ed, Up to Date (CD-ROM). 1999. View abstract
  156. Fishman L and Bousvaros A. Gastrointestinal issues in the child with developmental disabilities. International Seminars in Pediatric Gastroenterology and Nutrition. 1999; 8:1-9. View abstract
  157. Guzman C, Bousvaros A, Buonomo C, Nurko S. Intraduodenal hematoma complicating intestinal biopsy: case reports and review of the literature. Am J Gastroenterol. 1998 Dec; 93(12):2547-50. View abstract
  158. Teitelbaum JE, Perez-Atayde AR, Cohen M, Bousvaros A, Jonas MM. Minocycline-related autoimmune hepatitis: case series and literature review. Arch Pediatr Adolesc Med. 1998 Nov; 152(11):1132-6. View abstract
  159. Bousvaros A, Sundel R, Thorne GM, McIntosh K, Cohen M, Erdman DD, Perez-Atayde A, Finkel TH, Colin AA. Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis. Pediatr Pulmonol. 1998 Nov; 26(5):365-9. View abstract
  160. Hoppin AG, Kaplan LM, Zurakowski D, Leichtner AM, Bousvaros A. Serum leptin in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1998 May; 26(5):500-5. View abstract
  161. Bousvaros A, Zurakowski D, Duggan C, Law T, Rifai N, Goldberg NE, Leichtner AM. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr. 1998 Feb; 26(2):129-35. View abstract
  162. Hyams J, Davis P, Lerer T, Colletti RB, Bousvaros A, Leichtner A, Benkov K, Justinich C, Markowitz J. Clinical outcome of ulcerative proctitis in children. J Pediatr Gastroenterol Nutr. 1997 Aug; 25(2):149-52. View abstract
  163. Bousvaros A, Stevens AC, Strom TB, Murphy J, Lamont JT. Interleukin-2 fusion protein (DAB389IL-2) selectively targets activated human peripheral blood and lamina propria lymphocytes. Dig Dis Sci. 1997 Jul; 42(7):1542-8. View abstract
  164. Bousvaros A. Preventing relapse after surgery for Crohn's disease: where do we go from here? J Pediatr Gastroenterol Nutr. 1997 Jul; 25(1):114-5. View abstract
  165. Bousvaros A, Zurakowski D, Fishman SJ, Keough K, Law T, Sun C, Leichtner AM. Serum basic fibroblast growth factor in pediatric Crohn's disease. Implications for wound healing. Dig Dis Sci. 1997 Feb; 42(2):378-86. View abstract
  166. Shah S, Bousvaros A, Stevens AC. . Immunosuppressive Agents in Gastrointestinal Disease. Kresina T, ed. Manual of Immune Modulating Agents. 1997. View abstract
  167. Bousvaros A. Gastroenterologic Disorders. Graef J, Priebe C eds. Manual of Pediatric Therapeutics. 1997. View abstract
  168. Bousvaros A, Wang A, Leichtner AM. Tacrolimus (FK-506) treatment of fulminant colitis in a child. J Pediatr Gastroenterol Nutr. 1996 Oct; 23(3):329-33. View abstract
  169. Bross DA, Leichtner AM, Zurakowski D, Law T, Bousvaros A. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease. J Pediatr Gastroenterol Nutr. 1996 Aug; 23(2):164-71. View abstract
  170. Bousvaros A, Leichtner AM, Book L, Shigeoka A, Bilodeau J, Semeao E, Ruchelli E, Mulberg AE. Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506). Gastroenterology. 1996 Jul; 111(1):237-43. View abstract
  171. Bousvaros A. Immunosuppressive therapies in Pediatric Gastroenterology. Walker WA, Hamilton JR, Watkins JB, Walker-Smith JA, Durie PR. Pediatric Gastrointestinal Disease. 1995. View abstract
  172. Stevens AC, Shah S, Bousvaros A. Immunosuppressive Agents in Gastrointestinal Disease. Current Opinion in Gastroenterology. 1995; 11:554-561. View abstract
  173. Bousvaros A and Walker, WA. Immunology and Gastrointestinal Disease. Stiehm ER ed, Immunologic Disorders of Infants and Children. 1995; 697-741. View abstract
  174. Bousvaros A, LaMont JT. New immunotherapies and their potential for treatment of inflammatory bowel disease. Progress in Inflammatory Bowel Disease. 1993; 14:6-11. View abstract
  175. Bousvaros A, Kleinman RE. Immunology and Gastrointestinal Disease. Wyllie R and Hyams J eds., Pediatric Gastrointestinal Disease. 1993; 64-73. View abstract
  176. Bousvaros A, Walker WA. Basic gastrointestinal immunology. Bouchier IA, Hodgson HJ, Keighley MR eds., Gastroenterology: Clinical Science and Practice. 1993; 577-582. View abstract
  177. Bousvaros A, Antonioli DA, Winter HS. Ringed esophagus: an association with esophagitis. Am J Gastroenterol. 1992 Sep; 87(9):1187-90. View abstract
  178. Bousvaros A and Walker WA. Development of the Intestinal Mucosal Barrier. McDonald TT ed, Ontogeny of the Immune System of the Gut. 1991. View abstract
  179. Bousvaros A, Shamberger R, Winter HS. Abdominal Wall Defects. Rudolph Textbook of Pediatrics. 1991; 1040-1042. View abstract
  180. Bousvaros A and Winter HS. Diarrhea in the Immunodeficient Host. Rudolph's Textbook of Pediatrics. 1991; 1012-1015. View abstract
  181. Bousvaros A, Kirks DR, Grossman H. Imaging of neuroblastoma: an overview. Pediatr Radiol. 1986; 16(2):89-106. View abstract
  182. Borowitz MJ, Bousvaros A, Brynes RK, Cousar JB, Crissman JD, Whitcomb CC, Kerns BJ, Byrne GE. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience. Am J Pathol. 1985 Dec; 121(3):514-21. View abstract